Pfizer stock jumps on followup data from adolescent COVID vaccine trial
by from on (#5S7GR)
Pfizer (PFE) shares jumped higher Monday after the drugmaker published impressive followup data from a late stage trial of its coronavirus vaccine in adolescents.